KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Current Leases (2022 - 2025)

Historic Current Leases for Co-Diagnostics (CODX) over the last 4 years, with Q3 2025 value amounting to $744156.0.

  • Co-Diagnostics' Current Leases fell 1701.59% to $744156.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $744156.0, marking a year-over-year decrease of 1701.59%. This contributed to the annual value of $915619.0 for FY2024, which is 921.2% up from last year.
  • As of Q3 2025, Co-Diagnostics' Current Leases stood at $744156.0, which was down 1701.59% from $824458.0 recorded in Q2 2025.
  • Over the past 5 years, Co-Diagnostics' Current Leases peaked at $915619.0 during Q4 2024, and registered a low of $277290.0 during Q1 2023.
  • Moreover, its 4-year median value for Current Leases was $794516.0 (2023), whereas its average is $657706.5.
  • Its Current Leases has fluctuated over the past 5 years, first surged by 21011.29% in 2024, then crashed by 1701.59% in 2025.
  • Co-Diagnostics' Current Leases (Quarter) stood at $297209.0 in 2022, then skyrocketed by 182.09% to $838387.0 in 2023, then grew by 9.21% to $915619.0 in 2024, then decreased by 18.73% to $744156.0 in 2025.
  • Its Current Leases stands at $744156.0 for Q3 2025, versus $824458.0 for Q2 2025 and $902881.0 for Q1 2025.